MaryKCrowMD

PubMed

• 1 citations
  Systemic lupus erythematosus genetics: insights into pathogenesis and implications for therapy.
  Yogita Ghodke-Puranik, Mikhail Olferiev, Mary K Crow
  Nature Reviews. Rheumatology. 2024-10-01
• Identification of Gaps in Quality of Care and Good Practice Interventions in Rheumatoid Arthritis: Insights From a Literature Review and Qualitative Study of Nine Cent...
  Jeffrey R Curtis, Vivian P Bykerk, Mary K Crow, Maria I Danila, Boulos Haraoui
  ACR Open Rheumatology. 2024-09-01
• 1 citations
  Standing on Shoulders: Interferon Research From Viral Interference to Lupus Pathogenesis and Treatment.
  Mary K Crow, Mikhail Olferiev, Kyriakos A Kirou
  Arthritis & Rheumatology. 2024-07-01

Journal Articles

• Interferon-alpha and Angiogenic Dysregulation in Pregnant Lupus Patients Destined for Preeclampsia  
  Andrade D, Kim M, Blanco LP, Karumanchi SA, Koo GC, Redecha P, Kirou K, Alvarez AM, Mulla MJ, Crow MK, Abrahams VM, Kaplan MJ, Salmon JE, Arthritis Rheumatol., 1/1/2015
• Identification of Candidate Predictors of Lupus Flare  
  Crow MK, Olferiev M, Kirou KA, Trans Am Clin Climatol Assoc, 1/1/2015
• Type I and II Interferon Signatures in Sjogren's Syndrome Pathogenesis: Contributions in Distinct Clinical Phenotypes and Sjogren's Related Lymphomagenesis  
  Nezos A, Gravani F, Tassidou A, Kapsogeorgou EK, Voulgarelis M, Koutsilieris M, Crow MK, Mavragani CP, J Autoimmun, 1/1/2015
• Nilotinib (TasignaTM) In the Treatment of Early Diffuse Systemic Sclerosis: An Open-label, Pilot Clinical Trial  
  Gordon JK, Martyanov V, Magro C, Wildman HF, Wood TA, Huang WT, Crow MK, Whitfield ML, Spiera RF, Arthritis Res Ther, 1/1/2015
• A Surge in Anti-dsDNA Titer Predicts a Severe Lupus Flare within Six Months  
  Pan N, Amigues I, Lyman S, Duculan R, Aziz F, Crow MK, Kirou KA, Lupus., 1/1/2014
• Measuring Interferon Alpha and Other Cytokines in SLE  
  Olferiev M, Lliguicota M, Kirou KA, Crow MK, Methods Mol Biol., 1/1/2014
• Type I Interferon in the Pathogenesis of Lupus  
  Crow MK, J Immunol, 1/1/2014
• Imatinib Mesylate (Gleevec(TM)) In the Treatment of Diffuse Cutaneous Systemic Sclerosis: Results of a 24-month Open Label, Extension Phase, Single-centre Trial  
  Gordon J, Udeh U, Doobay K, Magro C, Wildman H, Davids M, Mersten JN, Huang WT, Lyman S, Crow MK, Spiera RF, Clin Exp Rheumatol, 1/1/2014
• Increased Serum Type I Interferon Activity in Organ-specific Autoimmune Disorders: Clinical, Imaging, and Serological Associations  
  Mavragani CP, Niewold TB, Chatzigeorgiou A, Danielides S, Thomas D, Kirou KA, Kamper E, Kaltsas G, Crow MK, Front Immunol., 1/19/2013
• Increased IFNalpha Activity and Differential Antibody Response in Patients with a History of Lyme Disease and Persistent Cognitive Deficits  
  Jacek E, Fallon BA, Chandra A, Crow MK, Wormser GP, Alaedini A., J Neuroimmunol, 1/1/2013
• Proteomic Analysis of Synovial Fluid from the Osteoarthritic Knee: Comparison with Transcriptome Analyses of Joint Tissues  
  Ritter SY, Subbaiah R, Bebek G, Crish J, Scanzello CR, Krastins B, Sarracino D, Lopez MF, Crow MK, Aigner T, Goldring MB, Goldring SR, Lee DM, Gobezie R, Aliprantis AO, Arthritis Rheum., 1/1/2013
• Felty's Syndrome Autoantibodies Bind to Deiminated Histones and Neutrophil Extracellular Traps  
  Dwivedi N, Upadhyay J, Neeli I, Khan S, Pattanaik D, Myers L, Kirou KA, Hellmich B, Knuckley B, Thompson PR, Crow MK, Mikuls TR, Csernok E, Radic M, Arthritis Rheum., 1/1/2012
• Synovial Fluid from Patients with Early Osteoarthritis Modulates Fibroblast-like Synoviocyte Responses to TLR-4 and TLR-2 Ligands via Soluble CD14  
  Nair A, Kanda V, Bush-Joseph C, Verma N, Chubinskaya S, Mikecz K, Glant TT, Malfait AM, Crow MK, Spear GT, Finnegan A, Scanzello CR, Arthritis Rheum., 1/1/2012
• Sarcoidosis Triggered by Interferon-Beta Treatment of Multiple Sclerosis: A Case Report and Focused Literature Review  
  Chakravarty SD, Harris ME, Schreiner AM, Crow MK, Semin Arthritis Rheum., 1/1/2012
• Identification of a Central Role for Complement in Osteoarthritis  
  Wang Q, Rozelle AL, Lepus CM, Scanzello CR, Song JJ, Larsen DM, Crish JF, Bebek G, Ritter SY, Lindstrom TM, Hwang I, Wong HH, Punzi L, Encarnacion A, Shamloo M, Goodma..., Nat Med., 1/6/2011
• Synovial Inflammation in Patients Undergoing Arthroscopic Meniscectomy: Molecular Characterization and Relationship with Symptoms  
  Scanzello CR, McKeon B, Swaim BH, Dicarlo E, Asomugha EU, Kanda V, Nair A, Lee DM, Richmond JC, Katz JN, Crow MK, Goldring SR, Arthritis Rheum., 1/1/2011
• A Loss-of-function Variant of the Antiviral Molecule MAVS Is Associated with a Subset of Systemic Lupus Patients  
  Pothlichet J, Niewold TB, Vitour D, Solhonne B, Crow MK, Si-Tahar M, EMBO Mol Med., 1/1/2011
• Degos Disease: A C5b-9/interferon-Alpha-mediated Endotheliopathy Syndrome  
  Magro CM, Poe JC, Kim C, Shapiro L, Nuovo G, Crow MK, Crow YJ, Am J Clin Pathol., 1/1/2011
• Imatinib Mesylate (Gleevec) In the Treatment of Diffuse Cutaneous Systemic Sclerosis: Results of a 1-year, Phase IIa, Single-arm, Open-label Clinical Trial  
  Spiera RF, Gordon JK, Mersten JN, Magro CM, Mehta M, Wildman HF, Kloiber S, Kirou KA, Lyman S, Crow MK, Ann Rheum Dis., 1/1/2011
• International Consensus for a Definition of Disease Flare in Lupus  
  Ruperto N, Hanrahan LM, Alarcon GS, Belmont HM, Brey RL, Brunetta P, Buyon JP, Costner MI, Cronin ME, Dooley MA, Filocamo G, Fiorentino D, Fortin PR, Franks AG Jr, Gil..., Lupus., 1/1/2011
• Autoimmune Disease Risk Variant of IFIH1 Is Associated with Increased Sensitivity to IFN-alpha and Serologic Autoimmunity in Lupus Patients  
  Robinson T, Kariuki SN, Franek BS, Kumabe M, Kumar AA, Badaracco M, Mikolaitis RA, Guerrero G, Utset TO, Drevlow BE, Zaacks LS, Grober JS, Cohen LM, Kirou KA, Crow MK,..., J Immunol., 1/1/2011
• A 26-year-old White Man with a Systemic Lupus Erythematosus Flare and Acute Multiorgan Ischemia: Vasculitis or Thrombosis?  
  Cherian J, Duculan R, Amigues I, Crow MK, Kirou KA, Arthritis Care Res (Hoboken)., 1/1/2011
• IRF5 Haplotypes Demonstrate Diverse Serological Associations Which Predict Serum Interferon Alpha Activity and Explain the Majority of the Genetic Association with Sys...  
  Niewold TB, Kelly JA, Kariuki SN, Franek BS, Kumar AA, Kaufman KM, Thomas K, Walker D, Kamp S, Frost JM, Wong AK, Merrill JT, Alarcon-Riquelme ME, Tikly M, Ramsey-Gold..., Ann Rheum Dis., 1/1/2011
• Association of the Response to TNF Antagonists with Plasma Type I Interferon Activity and Interferon-beta/alpha Ratios in Rheumatoid Arthritis Patients: A Post-hoc An...  
  Mavragani CP, La DT, Stohl W, Crow MK, Arthritis Rheum, 1/1/2010
• Long Interspersed Nuclear Elements (LINE-1): Potential Triggers of Systemic Autoimmune Disease  
  Crow MK, Autoimmunity, 1/1/2010
• Join now to see all

Books/Book Chapters

• Kelley's Textbook of Rheumatology 
  Chapter: Etiology and Pathogenesis of Systemic Lupus Erythematosus 
  Page 1269 - 1282Crow MKEditors: Gary S. Firestein, Ralph C. Budd, Sherine E. Gabriel, Iain B. McInnes and James R. O'Dell.ElsevierEdition 9th,2013
• Systemic Lupus Erythematosus 
  Chapter: Interferon-alpha in Systemic Lupus Erythematosus 
  Page 307 - 320Crow MKEditors: Robert G. Lahita.ElsevierEdition Fift,2011
• Essential Clinical Immunology 
  Chapter: Experimental Approaches to the Study of Autoimmune Rheumatic Diseases 
  Page 175 - 197Ashany D, Crow MKEditors: J B Zabriskie.Cambridge Medicine2009
• Dubois' Lupus Erythematosus 
  Chapter: Cytokines and Interferons in SLE 
  Page 161 - 175Crow MK and Kirou KAEditors: DJ Wallace and BH Hahn.Lippincott, Williams, and Wilkins, IncEdition Seve,2007
• Cecil's Textbook of Medicine 
  Chapter: Systemic Lupus Erythematosus 
  Page 2022 - 2031Crow MKEdition 23rd,2007
• Manual of Rheumatology and Outpatient Orthopedic Disorders 
  Chapter: Immunology for the Primary Care Physician 
  Page 14 - 20Crow MKEditors: AD Paget, AJ Beary III, A Gibofsky, T Sculco.Lippincott Williams & WilkinsEdition Fift,2006
• Rheumatology 
  Chapter: Cellular Immunology 
  Page 1347 - 1358Crow MKEditors: M Hochberg, A Silman, J Smolen, M Weinblatt, M Weisman.HarcourtEdition Thir,2003
• Principles of Corticosteroid Therapy 
  Chapter: Mechanisms of Glucocorticoid Action in the Immune System and in Inflammation 
  Page 41 - 65Crow MKEditors: AN Lin and SA Paget.Arnold Publishers, London2002
• Arthritis and Allied Conditions. A Textbook of Rheumatology 
  Chapter: Structure and Function of Monocytes/macrophages and Other Antigen Presenting Cells 
  Crow MKEditors: WJ Koopman.Lippincott, Williams & Wilkins, Philadelphia, PA2001
• Textbook of the Autoimmune Diseases 
  Chapter: Superantigens 
  Page 19 - 35Crow MKEditors: R Lahita, N Chiorazzi, W Reeves.Lippincott, Williams & Wilkins, Philadelphia, PA2000
• Manual of Rheumatology and Outpatient Orthopedic Disorders. Diagnosis and Therapy 
  Chapter: Raynaud Phenomenon 
  Kirou KA, Crow MKEditors: Paget S, Gibofsky A, Beary JF III.Lippincott Williams & Wilkins, PhiladelphiaEdition 4th,2000
• Lupus: Molecular and Cellular Pathogenesis 
  Chapter: Mechanisms of T-helper Cell Activation and Function in Systemic Lupus Erythematosus 
  Page 231 - 256Crow MKEditors: G Kammer and G Tsokos.Humana Press, Inc, Totowa, NJ1999
• Rheumatology 
  Chapter: SLE: Cellular Immunology 
  Page 49 - 62Crow MK, Friedman SMEditors: JH Klippel and P Dieppe.Gower Medical Publishing, London1993
• Systemic Lupus Erythematosus 
  Chapter: Etiologic Hypotheses for Systemic Lupus Erythematosus 
  Page 49 - 62Crow MK, Christian CLEditors: R.L. Lahita.1992
• Manual of Rheumatology and Outpatient Orthopedic Disorders 
  Chapter: Raynaud Phenomenon 
  Page 66 - 70Crow MKEditors: J.F. Beary, III, C.L. Christian and N.A. Johanson.Little, Brown and Company, Boston1987
• Immune Function in Man 
  Chapter: Use of Mitogens in the Evaluation of T Lymphocyte Function 
  Page 151 - 164Weksler ME, Kuntz MMEditors: GW Siskind, SD Litwin and CL Christian.Grune and Stratton, New York1976
• Join now to see all

Other

• Did Belief Win Out over Reason? Letter to the Editor 
  Crow MK, The New York Times
  1/8/2004
• Teaching Evolution in Kansas. Letter to the Editor 
  Crow MK, The New York Times
  1/1/1999